Chennai Noble Hospitals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 17-11-2024
- Paid Up Capital ₹ 0.50 M
as on 17-11-2024
- Company Age 3 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.29 Cr
as on 17-11-2024
- Revenue -40.66%
(FY 2023)
- Profit -78.52%
(FY 2023)
- Ebitda -73.52%
(FY 2023)
- Net Worth 21.41%
(FY 2023)
- Total Assets -7.75%
(FY 2023)
About Chennai Noble Hospitals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹5.29 Cr.
Krishnamma Polavaram, Balaji, Ravilla Baskaran, and One other member serve as directors at the Company.
- CIN/LLPIN
U85100TN2021PTC141599
- Company No.
141599
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Feb 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Chennai Noble Hospitals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Balaji  | Managing Director | 24-Feb-2021 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Krishnamma Polavaram | Whole-Time Director | 24-Feb-2021 | Current |
| Ravilla Baskaran | Whole-Time Director | 06-Jul-2021 | Current |
| Nischita Muppavarapu | Director | 06-Jul-2021 | Current |
Financial Performance and Corporate Structure Insights of Chennai Noble Hospitals.
Chennai Noble Hospitals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 40.66% decrease. The company also saw a substantial fall in profitability, with a 78.52% decrease in profit. The company's net worth Soared by an impressive increase of 21.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chennai Noble Hospitals?
In 2023, Chennai Noble Hospitals had a public holding of 90.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 03 Jun 2022 | ₹5.00 Cr | Open |
Hdfc Bank Limited Creation Date: 21 Oct 2021 | ₹2.88 M | Open |
How Many Employees Work at Chennai Noble Hospitals?
Chennai Noble Hospitals has a workforce of 86 employees as of Oct 19, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chennai Noble Hospitals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chennai Noble Hospitals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
